Buscar | MTSocial

Anuj Mrfr agregó una foto Health
2025-11-14 10:58:00 -

Uveitis Drug Market Growth: U.S. Drivers and Unmet Needs in Vision Preservation
The Uveitis Drug Market growth in the U.S. is underpinned by multiple factors: the prevalence of non-infectious uveitis, rising incidence of comorbid autoimmune disease, improved cross-specialty referrals (rheumatology to ophthalmology), and growing recognition of long-term complications like macular edema and vision loss. For deeper growth insights, see the Uveitis Drug Market growth. In the...

0 Commentarios 0 Acciones 552 Views 0 Vista previa

Please log in to like, share and comment!
Yuvraj Pawar agregó una foto Health
2026-01-05 11:40:21 -

Uveitis Drug Market Overview and Clinical Treatment Landscape
The Uveitis Drug Market is gaining increasing importance due to the rising prevalence of inflammatory eye disorders worldwide. Uveitis refers to inflammation of the uveal tract of the eye and can lead to severe complications such as vision loss if not treated appropriately. The condition may be caused by autoimmune diseases, infections, or trauma, and often requires long-term...

0 Commentarios 0 Acciones 80 Views 0 Vista previa

Please log in to like, share and comment!
Anuj Mrfr agregó una foto Health
2025-12-02 11:38:04 -

Steroid-Sparing Agents: Mitigating the Risks of Long-Term Corticosteroid Use
The need to control chronic, non-infectious uveitis without the long-term toxicity of corticosteroids has driven the essential role of steroid-sparing immunosuppressive agents. These drugs, which include antimetabolites like methotrexate and mycophenolate mofetil, and calcineurin inhibitors like cyclosporine, modulate the systemic immune response to control inflammation in the eye. They are...

0 Commentarios 0 Acciones 396 Views 0 Vista previa

Please log in to like, share and comment!